- Home
- DCO vs NVCR Comparison
DCO vs NVCR Comparison
Compare DCO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCO
- NVCR
- Stock Information
- Founded
- DCO 1849
- NVCR 2000
- Country
- DCO United States
- NVCR Switzerland
- Employees
- DCO N/A
- NVCR N/A
- Industry
- DCO Military/Government/Technical
- NVCR Medical/Dental Instruments
- Sector
- DCO Industrials
- NVCR Health Care
- Exchange
- DCO Nasdaq
- NVCR Nasdaq
- Market Cap
- DCO 1.4B
- NVCR 1.4B
- IPO Year
- DCO N/A
- NVCR 2015
- Fundamental
- Price
- DCO $93.11
- NVCR $12.52
- Analyst Decision
- DCO Strong Buy
- NVCR Buy
- Analyst Count
- DCO 4
- NVCR 7
- Target Price
- DCO $119.75
- NVCR $28.79
- AVG Volume (30 Days)
- DCO 99.3K
- NVCR 1.3M
- Earning Date
- DCO 11-06-2025
- NVCR 10-29-2025
- Dividend Yield
- DCO N/A
- NVCR N/A
- EPS Growth
- DCO 73.00
- NVCR N/A
- EPS
- DCO 2.65
- NVCR N/A
- Revenue
- DCO $795,078,000.00
- NVCR $630,160,000.00
- Revenue This Year
- DCO $6.15
- NVCR $6.68
- Revenue Next Year
- DCO $8.02
- NVCR $7.01
- P/E Ratio
- DCO $35.21
- NVCR N/A
- Revenue Growth
- DCO 2.42
- NVCR 14.58
- 52 Week Low
- DCO $51.76
- NVCR $10.87
- 52 Week High
- DCO $95.93
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- DCO 56.14
- NVCR 51.42
- Support Level
- DCO $88.84
- NVCR $11.98
- Resistance Level
- DCO $94.46
- NVCR $12.83
- Average True Range (ATR)
- DCO 2.11
- NVCR 0.54
- MACD
- DCO -0.05
- NVCR 0.18
- Stochastic Oscillator
- DCO 54.73
- NVCR 46.08
About DCO Ducommun Incorporated
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.